Child and Adolescent Psychiatry Trends. ADAMHS Board - 28 Oct 2014

Similar documents
Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care. Illinois Department of Children and Family Services

Curbing the High Rates of Psychotropic Medication Prescriptions among Children and Youth in Foster Care

New Jersey Department of Children and Families Policy Manual. Date: Chapter: A Health Services Subchapter: 1 Health Services

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents

PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE

ACUTE INPATIENT TREATMENT

Psychotropic Medication

Primary Care: Referring to Psychiatry

Oscar G. Morales. MD Founding Director McLean Hospital TMS

Antipsychotic Prior Authorization Request

Pediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form

Exhibit I-1 Performance Measures. Numerator (general description only)

Health Share Level of Care Authorization Form Adult Mental Health Services Initial Treatment Registration Form

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline

Psychiatric Care. Course Goals

Increasing Use of Psychotropics

Adult Mental Health Services applicable to Members in the State of Connecticut subject to state law SB1160

Antidepressants for treatment of depression.

Eating Disorders in Youth

Psychiatric Medications for Foster Youth: what we know and what we don t

Community Services - Eligibility

Connecticut Medicaid Emerging Adults

The Pediatric Behavioral Health Medication Initiative September 2016

Objectives. Mother-Infant Communication. Depression. Disclosures of Potential Conflicts. Why Is Perinatal Mental Health Important?

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

TITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder.

GUIDELINES FOR POST PEDIATRICS PORTAL PROGRAM

Child and Adolescent Residential Services Referral Packet

Caring for Our Kids: Are We Overmedicating Children in Foster Care?

Printing: Psychiatric Drugging of Infants and Toddlers in the US - Part I

Prevalence of Mental Illness

Pediatric Psychopharmacology

5 COMMON QUESTIONS WHEN TREATING DEPRESSION

Pharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines

Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives

Trends in the Prescribing of Psychotropic Medications to Preschoolers Original Contribution

EXAMINING CHILDREN S BEHAVIORAL HEALTH SERVICE USE AND EXPENDITURES,

Identifying Adult Mental Disorders with Existing Data Sources

SECTION 1. Children and Adolescents with Depressive Disorder: Summary of Findings. from the Literature and Clinical Consultation in Ontario

UnitedHealthcare Community (UHCCP) Louisiana Clinical Program Guidelines Record Supplemental Tool

Suicide in Montana Colleges and Universities. Karl Rosston, LCSW Suicide Prevention Coordinator (406)

GOALS FOR THE PSCYHIATRY CLERKSHIP

Quality Indicators in PSYCKES

Behavioral Health Hospital and Emergency Department Health Services Utilization

What s New in Psychotropic Prescribing for Children: Trends, Guidelines & Practice

FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality

Bipolar Disorder in Youth

Diagnosis & Assessment in Pediatric Psychopharmacology

Application of EventFlow to Model the Complexity and Continuity of Antipsychotic Use Among Youth

Are Racial/Ethnic Disparities in Youth Psychotropic Medication Due to Overuse by Whites?

Substance Abuse. Among current drinkers, men in nonmetro areas consume 5 or more drinks in one day than those in metro areas (56% vs.

Antidepressant Prior Authorization Request

BIOLOGICAL PSYCHOLOGICAL SOCIOLOGICAL. Session ID: 1011 June 16, Patti Varley, ARNP, MN, CS 1. This speaker has no conflict of interest to

HealthPartners Care Coordination Clinical Care Planning and Resource Guide EATING DISORDER

Taking Care: Child and Youth Mental Health TREATMENT OPTIONS

Unmanaged Behavioral Health Puts Your Company At Risk. Presented by: Dr. Sam Mayhugh Integrated Behavioral Health

Session ID: 1011 June 16, Patti Varley, ARNP, MN, CS APNA 10 th Annual Clinical Psychopharmacology aco ogy Institute June 14-17, 2012 Reston, VA

Table of Contents. 1.0 Policy Statement...1

Mood Disorders-Major Depression

Mental/Emotional Health Problems. Mood Disorders and Anxiety Disorders

Introducing ValueOptions Clinical Care Alerts

Young Adult Mental Health Overview

2) Percentage of adult patients (aged 18 years or older) with a diagnosis of major depression or dysthymia and an

Adult Mental Health Rehabilitation Treatment Request Form

Anticonvulsant Prior Authorization Request

The OAS Report. Issue Suicidal Thoughts, Suicide Attempts, Major Depressive Episode, and Substance Use among Adults.

Trauma Care in Children and Youth. Cecilia Margret MD, PhD, MPH March 24, 2018

D I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment.

Treatment Algorithm Treatment Algorithm

Mental health planners and policymakers routinely rely on utilization

Brief Notes on the Mental Health of Children and Adolescents

Cerebral Stimulant and ADHD Drugs Prior Authorization Request

Outpatient use of Atypical Antipsychotic Agents in the Pediatric Population Years

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018

.Wolters Kluwer Health

Table 1 Results of the 12-item General Health Questionnaire among caregivers who were or were not evacuated Not evacuated (N=46)

Pediatric Primary Care Mental Health Specialist Certification Exam. Detailed Content Outline

Developing mental health care in Europe - what can Germany learn from Member States and how can Member States profit from German experience?

Differentiating MDD vs. Bipolar Depression In Youth

INFORMED CONSENT FOR PSYCHOTROPIC MEDICATION

Application of Psychotropic Drugs in Primary Care

Lecture Outline Signs and symptoms in psychiatry Adjustment Disorders Other conditions that may be a focus of clinical attention

SUBSTANCE USE/ABUSE CODING FACT SHEET FOR PRIMARY CARE CLINICIANS

Orientation for New Child and Adolescent Psychiatry Residents: Module Two - Assessment

Massachusetts Department of Developmental Services. Medication Review

MCPAP Clinical Conversations: Depression Update: Rollout of New MCPAP Depression Algorithm

Who, What, Where, Why and How of Primary Care Paediatric Mental Health Continuing Medical Education Events

5/12/11. Educational Objectives. Goals

Behavioral Health Assessment & Treatment in Children and Youth

UPMC SAFE-T Training Adapted for Pediatric Primary Care. Sheri L. Goldstrohm, Ph.D.

Taking Care: Child and Youth Mental Health PSYCHOSIS TREATMENT OPTIONS

Elevating the quality of care for the highest risk children in foster care. David Rubin, MD, MSCE Meredith Matone, MHS Kathleen Noonan, JD

Using Evidence to Support Recovery through Comprehensive Community Services (CCS) Presentation Objectives. What is CCS? 10/17/2018

Hypomania spectrum disorder in adolescence: a 15-year follow-up of non-mood morbidity in adulthood

Psychotropic Medication Utilization Review (PMUR) Process for STAR Health Members

NEURO/PSYCH FOR PRIMARY CARE. San Juan, Puerto Rico InterContinental San Juan February 25 28, 2016

Review: Psychosocial assessment and theories of development from N141 and Psych 101

Improving Mental Health Care: A Case Study

Treatment Compliance in Mental Health Practice

Transcription:

Child and Adolescent Psychiatry Trends ADAMHS Board - 28 Oct 2014

Current Need for Child and Adolescent Psychiatrists There are currently approximately 7400 Child and Adolescent Psychiatrists in Practice in the US By 2020, there will be approximately 8300 in practice In 2000 the estimated need was 13,000-22,000

Why Can t We Meet the Need with Other Specialties? CAP requires specialized training, education, and experience Number of CAP rotations required by pediatric residencies...zero Nurse practitioners - only a fraction of the education and experience of physicians

CAP in the United States

CAP in the United States

CAP in Ohio

CAP in Ohio

Current State of Diagnosis and Care Prevalence rates for CAP mental illness range from 17-22% 15% have some significant functional impairment Only 1 in 5 receives appropriate treatment As many as 50% of mental health disorders go undiagnosed in a primary care setting

Suicide Remains Ongoing Crisis Suicide is the third leading cause of death in youth ages 15 to 24 More teenagers and young adults die from suicide than from cancer, heart disease, AIDS, birth defects, stroke, pneumonia, influenza and chronic lung disease combined Over 90 percent of children and adolescents who commit suicide have a mental disorder

Trends in Medication Usage About 8 million children are on one or more medications for mental illness (about 1 in 13 children) From 1987-1996 there was a 2-3x increase in children taking psychotropic medications From 1993-2002 there was a 6x increase in office based visits that included prescribing of an antipsychotic medication

ADHD Trends in Diagnoses

Trends in Diagnoses Bipolar Disorder Annual number of youth office-based visits with a diagnosis of bipolar disorder increased from 25 (1994-1995) to 1003 (2002-2003) visits per 100 000 population In 1999 to 2003, most youth bipolar disorder visits were by males (66.5%), whereas most adult bipolar disorder visits were by females (67.6%) Youth were more likely than adults to receive a comorbid diagnosis of attentiondeficit/hyperactivity disorder (32.2% vs 3.0%, respectively; P <.001) Most youth (90.6%) and adults (86.4%) received a psychotropic medication during bipolar disorder visits, with comparable rates of mood stabilizers, antipsychotics, and antidepressants prescribed for both age groups

Depression Trends in Diagnoses PERCENTAGE OF YOUTH AGES 12 17 WHO EXPERIENCED A MAJOR DEPRESSIVE EPISODE (MDE) IN THE PAST YEAR BY AGE AND GENDER, 2004 2011

Trends in Medication Usage More recent data shows that 6.2% of Medicaid children and 4.8% of privately insured children took at least one psychiatric medication in the last year Medicaid children are twice as likely to be prescribed an antipsychotic medication versus privately insured children

Trends in Medication Usage Only 31% of psychotropic medications are FDA approved for children and adolescents 6-17 years old 75% of medications are prescribed off label for this group by some estimates

Factors Impacting Increased Medication Usage Increased awareness of severe mental health problems in young children Development of medications considered safer than their older counterparts Increased experience of practicing providers treating younger populations Increased behavioral expectations of very young children in structured settings, such as childcare or preschool

Factors Impacting Increased Medication Usage Medication usage proliferated by primary care physicians Less access to CAP Limited insurance coverage for residential and inpatient care Few outpatient psychotherapy providers Result: PCPs provide over 50% of mental health treatment Prescribe majority of psychotropic medications to children and adolescents 75% of scripts for anxiolytics, antipsychotics, and mood stabilizers have been prescribed by PCPs and not psychiatrists

Children in Foster Care Increasingly vulnerable to excessive and inappropriate medication usage High incidence of neglect, psychosocial chaos, abuse PTSD and RAD can complicate the care picture Further risk factors for escalation of dubious use of medications include incarceration, poverty, or inpatient psychiatric hospitalization Medicaid data shows that from 2002-2007, the rate of polypharmacy in foster children was 1-14%; the rate of antipsychotic use was 3-22% States still report many cases where foster children have been given psychotropic medication without proper legal consent

CAP Mental Illness and Scope of Medication Usage Our dilemma: the earlier onset of mental illness in the absence of treatment, the more functional impairment, quality of life, and cost to society as these children enter adulthood Our concern: More recent well-designed pediatric psychotropic drugs studies have pointed to a greater or different profile of susceptibility to adverse effects in children compared to adults. Other dissimilarities include developmentally dependent variations in drug effectiveness, paradoxical drugs reactions in susceptible youth and pharmacokinetic differences based on age and developmental anatomical/ physiological maturity